OPPENHEIMER | Jotup

Oppenheimer Expands Technology Investment Banking Group with Addition of Yogesh Amle

Retrieved on:

월요일, 5월 13, 2024

TMT, Barclays, Yogesh, BMO Capital Markets, Research, Oppenheimer Holdings, CFA, Credit Suisse, Cryptocurrency

NEW YORK, May 13, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank and subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that it has expanded its Technology Investment Banking group with the addition of Yogesh Amle as Managing Director, co-Head of Infrastructure Software. He will be based in Oppenheimer's San Francisco office and report to Robin Graham, the firm's Head of Technology Investment Banking.

Key Points:

NEW YORK, May 13, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank and subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that it has expanded its Technology Investment Banking group with the addition of Yogesh Amle as Managing Director, co-Head of Infrastructure Software.
He will be based in Oppenheimer's San Francisco office and report to Robin Graham, the firm's Head of Technology Investment Banking.
He has also worked in various roles in Citi, Barclays and J.P. Morgan's respective Technology, Media and Telecom (TMT) Investment Banking groups.
Oppenheimer's Technology Investment Banking group is comprised of 15 senior bankers with deep sub-sector expertise across more than 10 sectors within Technology.

Trevi Therapeutics to Participate in Upcoming Conferences

Retrieved on:

목요일, 5월 9, 2024

Corporation, Idiopathic pulmonary fibrosis, University, NIHR, NHS foundation trust, IPF, Respiratory Medicine, Doctor of Philosophy, MB, Chronic cough, University of Manchester, Panel, RCC, FRCP, Therapy, Management

Corporate Presentation: May 14 at 12:00 p.m.

Key Points:

Corporate Presentation: May 14 at 12:00 p.m.
ET
Presenter: Jacky Smith, MB, ChB, FRCP, PhD, Professor of Respiratory Medicine at the University of Manchester, and an Honorary Consultant at Manchester University NHS Foundation Trust.
Director of the NIHR Manchester Clinical Research Facility, Respiratory Theme Lead in the NIHR Manchester Biomedical Research Centre and an NIHR Senior Investigator.
Panel Members: Experts in the field of chronic cough include Professor Peter Dicpinigaitis, Professor Jacky Smith, and Professor Alyn Morice.

Runway Growth Finance Corp. Announces Pricing of Secondary Offering of Common Stock by Selling Stockholder

Retrieved on:

금요일, 5월 10, 2024

Sale, Prospectus, UBS, RBC Capital Markets, Morgan Stanley, Suite, Security (finance), Compass point, Oppenheimer Holdings, Form, Varick Street, EDGAR, Keefe, Bruyette & Woods, 2nd Floor, BofA Securities, Wells Fargo, ATTN:

In connection with the offering, the Selling Stockholder has granted the underwriters a 30-day option to purchase up to 562,500 additional shares of the common stock offered by the Selling Stockholder.

Key Points:

In connection with the offering, the Selling Stockholder has granted the underwriters a 30-day option to purchase up to 562,500 additional shares of the common stock offered by the Selling Stockholder.
Subject to customary closing conditions, the offering is expected to settle and close on or about May 14, 2024.
Runway Growth is not selling any shares of its common stock in the offering and will not receive any proceeds from the offering.
A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the offering is available on the SEC’s website located at www.sec.gov .

SHLS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Shoals Technologies Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on:

월요일, 5월 6, 2024

Copper, News, Complaint, Class, Defendant, Court, Person, Cryptocurrency

The 2Q23 10-Q disclosed that Shoals had recorded a warranty liability of $9.3 million related to the shrinkback issue.

Key Points:

The 2Q23 10-Q disclosed that Shoals had recorded a warranty liability of $9.3 million related to the shrinkback issue.
As investors belatedly found out, Shoals had installed defective wire harnesses in at least 300 solar fields.
or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Oppenheimer Expands Its Investment Banking Capabilities with the Hires of Dmitry Gladkov and Konstantin Derkatschew

Retrieved on:

수요일, 5월 8, 2024

Goldman Sachs, Emerging market, Development, Oppenheimer Holdings, Barclays, UBS, Capital market, Research, J. P. Morgan, Investment, Renaissance Capital, Head, Security (finance)

NEW YORK, May 8, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Dmitry Gladkov and Konstantin Derkatschew. Both will be based in London and serve as a Managing Director.

Key Points:

NEW YORK, May 8, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Dmitry Gladkov and Konstantin Derkatschew.
Gladkov and Derkatschew come to the firm from Renaissance Capital and will jointly head the newly established Capital Markets Group focusing primarily on Emerging Europe and Central Asia regions.
"The addition of Dmitry and Konstantin will allow Oppenheimer to further its strategic expansion across advisory and capital markets in Emerging Europe and Central Asia," Lami said.
Derkatschew joins Oppenheimer with over 15 years of investment banking and capital markets experience.

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock

Retrieved on:

금요일, 5월 3, 2024

Sale, Prospectus, Prader–Willi syndrome, Equity, Guggenheim Partners, PWS, Research, Nicollet Mall, Madison Avenue, Oppenheimer Holdings, Public expenditure, Form, Therapy, Tablet, Attention, Telephone, Security (finance)

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $46.00 per share.

Key Points:

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $46.00 per share.
The gross proceeds of the public offering are expected to be approximately $138.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
Soleno has also granted the underwriters a 30-day option to purchase up to 450,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
Piper Sandler, Guggenheim Securities, Cantor Fitzgerald & Co. and Oppenheimer & Co. are acting as joint book-running managers for the public offering.

FiscalNote to Present at Upcoming Investor Conferences

Retrieved on:

금요일, 5월 3, 2024

FiscalNote will participate virtually and host investor meetings.

Key Points:

FiscalNote will participate virtually and host investor meetings.
FiscalNote will present and host investor meetings.
B. Riley Securities 24th Annual Institutional Investor Conference - Wednesday, May 22, 2024 at the Beverly Hilton Hotel, Beverly Hills, CA.
For more information about the conferences, please contact representatives at Oppenheimer & Co., Needham & Co., B. Riley Securities, and Northland Securities.

Valens Semiconductor to Participate in Upcoming Investor Conferences

Retrieved on:

목요일, 5월 2, 2024

VLN, Virtual, CFO, HOD, Conference, Valens Semiconductor

HOD HASHARON, Israel, May 2, 2024 /PRNewswire/ -- Valens Semiconductor (NYSE: VLN), a leader in high-performance connectivity, today announced that it will participate in the following investor events in May 2024.

Key Points:

HOD HASHARON, Israel, May 2, 2024 /PRNewswire/ -- Valens Semiconductor (NYSE: VLN), a leader in high-performance connectivity, today announced that it will participate in the following investor events in May 2024.
Oppenheimer 9th Annual Emerging Growth Conference (Virtual): On Thursday, May 9, 2024.
Guy Nathanzon, CFO of Valens Semiconductor, will participate in one-on-one meetings.
For more information about the events or questions about registration, interested parties should reach out to their contacts at Oppenheimer.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm

Retrieved on:

월요일, 4월 22, 2024

Copper, Sickle cell disease, FDA, Cancer, Elivaldogene autotemcel, DSM-IV codes, SCD, News, Food, Truist, Blue, Complaint, Class, Barclays, Meta, History, P.C, Patient, Defendant, False, Health, Medicare, NBH, BLA, Metamaterial, File, Biotechnology, Disclosure, Cryptocurrency

In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients.

Key Points:

In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients.
This model incentivizes agilon and its contracted physician partners to focus on preventive care and improve health outcomes in order to control costs.
If the total cost of caring for patients is less than the fixed payments agilon receives, it realizes a profit.
On this news, agilon’s stock price fell $2.23, or 13.2 percent, to close at $14.66 on November 3, 2023.

SHLS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Shoals Technologies Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on:

월요일, 4월 22, 2024

Copper, News, Complaint, Class, Defendant, Court, Person, Cryptocurrency

The 2Q23 10-Q disclosed that Shoals had recorded a warranty liability of $9.3 million related to the shrinkback issue.

Key Points:

The 2Q23 10-Q disclosed that Shoals had recorded a warranty liability of $9.3 million related to the shrinkback issue.
As investors belatedly found out, Shoals had installed defective wire harnesses in at least 300 solar fields.
or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.